Efficacy of ipragliflozin as monotherapy or as add‐on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics

Abstract

Ipragliflozin is a useful oral antidiabetic medication for patients with a wide range of background characteristics.